Alnylam Pharmaceuticals
ALNY
#873
Rank
โ‚น2.766 T
Marketcap
โ‚น20,676
Share price
-1.01%
Change (1 day)
-45.78%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company